FDA reviewers raise red flags for Amgen cancer vaccine ahead of AdComm

Carly Helfand

Wednesday's a big day for , whose dual-acting /viral therapy is coming up for review by an FDA panel of experts.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS